two
nonsynchron
event
affect
manag
communityacquir
pneumonia
cap
spiral
empiric
cap
golden
era
clinic
microbiolog
develop
broadspectrum
antibiot
led
widespread
empir
use
without
ascertain
etiolog
infect
microb
unfortun
approach
clash
second
event
advent
molecularbas
microbiolog
identifi
caus
pathogen
rapidli
point
care
urinari
antigen
effect
rapid
test
allow
target
therapi
legionnair
diseas
point
care
high
specif
allow
clinician
administ
appropri
antilegionella
therapi
base
singl
rapid
test
howev
low
sensit
mean
notabl
number
case
legionnair
diseas
go
undiagnos
test
especi
cultur
perform
cultur
legionella
readili
avail
cultur
perform
epidemiolog
identif
sourc
bacterium
ascertain
molecular
fingerprint
patient
put
sourc
strain
recommend
resurrect
basic
principl
infecti
diseas
identifi
microbi
etiolog
infect
use
narrow
target
antimicrobi
therapi
reduc
antimicrobi
overus
subsequ
antimicrobi
resist
basic
principl
must
appli
concert
tradit
newer
test
clinic
microbiolog
laboratori
abbrevi
cap
communityacquir
pneumonia
n
issu
chest
see
page
shimada
et
al
present
systemat
review
metaanalysi
urinari
antigen
test
legionella
one
success
diagnost
aid
infecti
diseas
today
rapid
test
result
seen
within
min
test
impact
point
care
one
common
lethal
infecti
diseas
face
mankind
communityacquir
pneumonia
cap
cap
remain
hot
clinic
topic
emerg
pathogen
sever
acut
respiratori
syndrom
sar
coronaviru
avian
influenza
viru
coupl
emerg
resist
microb
antibacteri
antivir
agent
made
infect
constant
challeng
howev
follow
two
import
event
transpir
come
climax
past
year
develop
antimicrobi
agent
direct
common
fear
pathogen
cap
advent
innov
technolog
rapid
identif
microbi
pathogen
cap
one
urinari
antigen
test
legionella
event
favor
patient
care
paradox
nonsynchron
chest
commentari
pharmaceut
industri
advent
quinolon
respiratori
tract
macrolid
led
tremend
reduct
morbid
mortal
oncefear
legionnair
diseas
high
mortal
seen
origin
american
legion
outbreak
result
physicianclinician
capabl
initi
empir
therapi
cover
like
pathogen
cap
one
two
broadspectrum
antibiot
empir
broadspectrum
therapi
erad
offend
pathogen
assur
favor
outcom
pneumonia
common
infecti
caus
hospit
admiss
notabl
morbid
prescript
activ
antibiot
therapi
salutari
impact
outcom
situat
often
suffici
urgent
antibiot
therapi
administ
base
suspicion
diagnosi
result
laboratori
test
clinic
relev
must
rapidli
avail
point
care
polymeras
chain
reaction
methodolog
develop
success
autom
instrument
har
power
molecular
biolog
appli
success
laboratori
test
molecularbas
test
final
move
research
bench
clinic
diagnost
laboratori
becom
commerci
avail
complex
instrument
survey
entir
pantheon
pathogen
includ
viral
pathogen
classic
bacteri
pathogen
cap
moreov
result
avail
within
hour
obtain
patient
specimen
technic
advanc
allow
target
antimicrobi
therapi
numer
pathogen
cap
identifi
point
care
appear
longanticip
golden
era
clinic
microbiolog
final
impact
medic
practic
cap
disappointingli
studi
shown
knowledg
ident
offend
pathogen
less
impact
outcom
anticip
target
pathogen
narrowspectrum
antibiot
laboratori
result
becom
avail
often
exploit
rather
therapi
broadspectrum
agent
agent
mere
continu
physician
result
unanticip
insidi
deemphasi
use
clinic
microbiolog
occur
therein
lie
asynchron
exampl
infecti
diseas
societi
america
american
thorac
societi
guidelin
longer
recommend
sputum
cultur
gram
stain
blood
cultur
legionella
test
routin
necess
disappointingli
microbiolog
test
instead
list
option
guidelin
import
function
clinic
microbiolog
laboratori
usurp
stamped
empir
antibiot
qualiti
assur
guidelin
requir
therapi
initi
within
h
diagnosi
cap
place
pressur
physician
provid
immedi
antimicrobi
therapi
point
care
also
led
unanticip
practic
administ
empir
broadspectrum
antibiot
patient
pneumonia
antimicrobi
resist
expect
consequ
requisit
wait
period
requir
specimen
collect
deliveri
laboratori
microbiolog
process
becom
major
impedi
target
antimicrobi
therapi
deemphasi
clinic
microbiolog
led
budgetari
cut
laboratori
loss
train
personnel
moreov
mani
laboratori
move
proxim
patient
locat
outsid
hospit
physic
separ
produc
disconnect
collabor
natur
infecti
diseas
manag
clinic
microbiolog
urinari
antigen
legionella
develop
late
one
success
rapid
diagnost
microbiolog
test
unfortun
test
reliabl
detect
one
speci
legionella
pneumophila
one
serogroup
nevertheless
signific
advantag
direct
fluoresc
antibodi
test
legionella
antibodi
serolog
cultur
includ
rel
low
cost
rapid
perform
importantli
result
affect
manag
point
care
result
urinari
antigen
test
common
method
use
make
diagnosi
legionnair
diseas
dramat
increas
proport
case
legionnair
diseas
diagnos
result
urin
antigen
test
occur
worldwid
europ
case
diagnos
use
urin
antigen
test
compar
among
case
legionnair
diseas
report
center
diseas
control
prevent
signific
increas
seen
proport
patient
posit
urin
test
diagnosi
result
urin
antigen
test
increas
period
proport
like
higher
today
simultan
use
legionella
cultur
direct
fluoresc
antibodi
test
notabl
declin
exampl
travelassoci
case
legionnair
diseas
diagnos
use
cultur
compar
diagnos
use
urin
antigen
test
among
healthcareassoci
case
legionnair
diseas
report
unit
state
diagnos
use
urin
antigen
test
cultur
test
evolv
radioimmunoassay
enzym
immunoassay
immunochromatograph
test
binax
urinari
antigen
test
binax
portland
metaanalysi
shimada
et
al
shown
among
three
immunochromatograph
assay
immunochromatograph
test
binax
urinari
antigen
test
binax
sensit
specif
respect
compar
respect
respect
two
test
import
note
differ
format
substanti
differ
sensit
specif
would
expect
metaanalysi
shimada
et
al
give
good
overview
advantag
weak
legionella
urinari
antigen
number
point
worth
reemphas
advantag
urinari
antigen
test
simplic
collect
rapid
test
result
test
much
less
influenc
prior
antibiot
therapi
sputum
cultur
specif
high
shown
metaanalysi
messag
relev
clinician
test
result
posit
initi
antilegionella
antibiot
therapi
imper
howev
metaanalysi
also
shown
sensit
high
even
sensit
commerci
avail
test
least
onequart
patient
confirm
legionellosi
neg
test
result
sensit
also
affect
cours
infect
milder
case
diseas
may
suffici
advanc
amount
antigen
urin
detect
although
center
diseas
control
prevent
report
urin
antigen
test
sensit
cultur
found
perform
properli
select
dyecontain
media
cultur
use
gold
standard
case
legionnair
diseas
patient
cap
caus
l
pneumophila
caus
l
pneumophila
serogroup
next
common
speci
obtain
patient
cap
legionella
micdadei
legionella
longbeacha
surprisingli
l
longbeacha
common
australia
new
zealand
reason
uncertain
consequ
urinari
antigen
less
valuabl
countri
serogroup
especi
hospitalacquir
infect
also
caus
diseas
particularli
l
pneumophila
serogroup
urinari
antigen
insensit
speci
serogroup
diagnosi
legionellosi
due
serogroup
l
pneumophila
speci
depend
recoveri
organ
cultur
serolog
antibodi
test
anoth
consequ
deemphasi
clinic
microbiolog
decreas
use
legionella
cultur
mani
hospit
outsourc
test
refer
laboratori
caus
unaccept
delay
report
result
often
clinician
order
urin
antigen
test
without
submit
request
sputum
cultur
urin
antigen
test
legionella
cultur
perform
site
maxim
effect
urin
antigen
test
result
avail
h
instead
day
allow
opportun
initi
target
antilegionella
therapi
quickli
eas
perform
ict
cardtyp
urin
test
make
ideal
use
ed
longterm
care
facil
physician
offic
believ
cultur
also
readili
avail
within
hospit
hospit
water
suppli
colon
legionella
hospit
unit
state
may
well
colon
cultur
allow
isol
organ
molecular
fingerprint
perform
microbiolog
laboratori
freez
isol
forward
public
health
laboratori
anticip
epidemiolog
investig
simpl
practic
hold
respiratori
specimen
refriger
day
allow
microbiolog
laboratori
retriev
respiratori
specimen
urin
antigen
test
result
posit
one
reason
mani
case
legionnair
diseas
includ
pittsburgh
pneumonia
agent
l
micdadei
seen
pittsburgh
pa
widespread
avail
cultur
capabl
pittsburgh
commun
hospit
well
academ
tertiari
care
center
thu
case
legionnair
diseas
diagnos
annual
pittsburgh
area
state
given
recent
increas
incid
legionnair
diseas
unit
state
europ
motiv
revers
trend
provid
public
health
offici
opportun
determin
sourc
exposur
isol
cultur
patient
use
diagnosi
case
find
identif
sourc
articl
shimada
et
al
conclud
plea
highqual
studi
howev
opinion
studi
statist
rigor
key
key
resurrect
use
cultur
develop
rapid
diagnost
test
identifi
legionella
speci
serogroup
strengthen
role
clinic
microbiolog
laboratori
although
dramat
progress
made
molecular
biolog
increas
role
nucleic
acid
amplif
sequenc
type
method
remain
need
valid
newer
test
result
molecular
diagnost
assay
must
correl
clinic
find
cultur
result
physician
must
resurrect
applic
basic
principl
infecti
diseas
identifi
etiolog
cap
use
narrow
target
therapi
full
clinic
microbiolog
armamentarium
newer
molecular
test
must
exploit
return
sputum
gram
stain
sputum
cultur
blood
cultur
also
would
provid
inform
allow
use
penicillin
pneumococc
pneumonia
advent
sensit
rapid
test
viral
pathogen
especi
influenza
empir
antibacteri
agent
therapi
ineffect
promot
drug
resist
replac
effect
antivir
therapi
truli
golden
era
clinic
microbiolog
reduct
antibiot
misus
overus
need
smarter
use
weapon
dispos
includ
tradit
test
newer
molecularbas
test
